Table 3.
Analysis of postoperative results: redo pts and control group
| Redo patients (n = 49) | Control group (n = 49) | p value | |
|---|---|---|---|
| Matched variables | |||
| Sex (M/F) | 22/27 | 27/22 | 0.42 |
| Age | 41 (31–51) | 46 (34–53) | 0.32 |
| Follow-up time (months) | 62 (24–151) | 87 (44–125) | 0.52 |
| Eckardt score | 2 (1–5) | 2 (1–3) | 0.20 |
| Radiological stage | > 0.99 | ||
| Stage I | 8 (16.3%) | 8 (16.3%) | |
| Stage II | 23 (46.9%) | 23 (46.9%) | |
| Stage III | 10 (20.4%) | 10 (20.4%) | |
| Stage IV | 8 (16.3%) | 8 (16.3%) | |
| Previous endoscopic dilations (yes/no) | 39 (79.6%) | 39 (79.6%) | > 0.99 |
| Results (unmatched outcome variables) | |||
| Operative time (min) | 180 (144–222) | 125 (110–150) | < 0.01 |
| Intraoperative perforations (yes/no) | 2 (4%) | 1 (2%) | > 0.99 |
| Hospital stay (days) | 4 (3–6) | 4 (3–6) | 0.32 |
| Postoperative complications (yes/no) | 5 (10.2%) | 0 | 0.06 |
| Postoperative complications: Clavien Dindo | NA | ||
| Grade 1 | 1 | 0 | |
| Grade 2 | 1 | 0 | |
| Grade 3 | 3 | 0 | |
| Grade 4 | 0 | 0 | |
| Failure | 9 (18.4%) | 5 (10.2%) | 0.39 |
| Endoscopic Esophagitis | 10/29 (34.5%) | 0 | < 0.0001 |
| Abnormal 24 h pH study | 11/26 (42.3%) | 1/29 (3.5%) | 0.0007 |
| Overall GERD | 16/29 (55.2%) | 1/29 (3.5%) | < 0.0001 |